I. Dr. Selvaraj
Indian Railways Medical Service
B.Sc., M.B.B.S., M.D.,D.P.H., D.I.H., PGCHFW ( NIHFW,New Delhi)., Life member of Indian Association of Preventive & Social Medicine Life member of Indian Public Health Association Life member of Indian Medical Association
As I am one of the strong supporter of super course, I am dedicating this presentation to the public health students (Post graduate Diploma in Public Health, M.D Community Medicine)
METABOLIC SYNDROME Metabolic syndrome is a cluster of risk factors which is responsible for excess of cardiovascular disease morbidity among overweight and Obese patients and those persons with type 2 diabetes mellitus. The National Cholesterol Education ProgramAdult Treatment Panel (NCEP-ATP III) identified metabolic syndrome as an independent risk factor for cardiovascular disease and considered it an indication for intensive lifestyle modification.
W.H.O DEFINITION OF MEATBOLIC SYNDROME INSULIN RESISTANCE+ TWO OF THE FOLLOWING:
1.Abdominal/central obesity: Waist to hip ratio: > 0.90 (men), > 0.85 (women), or BMI > 30 2. Hypertriglyceridemia: 150 mg per dL 3. Low HDL cholesterol: < 35 mg perdl for men, < 39 mg per dL for women 4. High blood pressure: 140/90 mm Hg or documented use of antihypertensive therapy 5. High fasting glucose: Impaired glucose tolerance, impaired fasting glucose, insulin resistance, or diabetes 6. Microalbuminuria Urinary albumin to creatinine ratio: 30 mg per g, or albumin excretion rate: 20 mcg per minute
Review of literature
A CROSS SECTIONAL STUDY ON METABOLIC SYNDROME
JUSTIFICATION OF THE STUDY
As there is an epidemiological transition from communicable to non-communicable diseases The prevalence of Metabolic syndrome is reported to be very high in developing countries. The components of the metabolic are syndrome important risk factors for the development of Coronary Heart Diseases and for Type 2 diabetes. Hence this study will be ideal to estimate the prevalence of Metabolic syndrome in the developing countries
OBJECTIVE
1. To determine the prevalence of metabolic syndrome using NCEP adult treatment panel-3 (ATP-3) guidelines 2. To determine the role of lifestyle risk factors in the development of metabolic syndrome with particular reference to physical activity, smoking, diet and alcohol consumption.
CASE DEFINITION: Metabolic syndrome is defined in accordance with NCEP - ATP III as the presence of 3 or more of the following characteristics: 1. Waist circumference > 102 cm in men and > 88 cm in women 2. Triglyceride levels > or = 150 mg/dl, 3. High density lipoprotein cholesterol < 40 mg/dl in men and < 50 mg/dl in women 4. Blood pressure > or = 130/85 mm hg 5. and Fasting serum glucose > or = 110 mg/dl.
METHODS
STUDY DESIGN: Cross sectional study
SAMPLE SIZE CALCULATION
Sample Size (N) = (Zpq)/L Z=1.96 Ordinate value for =5%...